1 Study Coverage
1.1 Over The Counter (OTC) Drugs Revenue in Over The Counter (OTC) Drugs Business (2017-2022) & (US$ Million) Introduction
1.2 Global Over The Counter (OTC) Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Over The Counter (OTC) Drugs Market Size for the Year 2017-2028
1.2.2 Global Over The Counter (OTC) Drugs Market Size for the Year 2017-2028
1.3 Over The Counter (OTC) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Over The Counter (OTC) Drugs in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Over The Counter (OTC) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Over The Counter (OTC) Drugs Market Dynamics
1.4.1 Over The Counter (OTC) Drugs Industry Trends
1.4.2 Over The Counter (OTC) Drugs Market Drivers
1.4.3 Over The Counter (OTC) Drugs Market Challenges
1.4.4 Over The Counter (OTC) Drugs Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Over The Counter (OTC) Drugs by Type
2.1 Over The Counter (OTC) Drugs Market Segment by Type
2.1.1 Analgesics
2.1.2 Dermatology Products
2.1.3 Gastrointestinal Products
2.1.4 Vitamins, Mineral, and Supplements (VMS)
2.1.5 Weight Loss/Dietary Products
2.1.6 Ophthalmic Products
2.1.7 Sleeping Aids
2.1.8 Others
2.2 Global Over The Counter (OTC) Drugs Market Size by Type (2017, 2022 & 2028)
2.3 Global Over The Counter (OTC) Drugs Market Size by Type (2017-2028)
2.4 United States Over The Counter (OTC) Drugs Market Size by Type (2017, 2022 & 2028)
2.5 United States Over The Counter (OTC) Drugs Market Size by Type (2017-2028)
3 Over The Counter (OTC) Drugs by Application
3.1 Over The Counter (OTC) Drugs Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacy
3.1.4 Others
3.2 Global Over The Counter (OTC) Drugs Market Size by Application (2017, 2022 & 2028)
3.3 Global Over The Counter (OTC) Drugs Market Size by Application (2017-2028)
3.4 United States Over The Counter (OTC) Drugs Market Size by Application (2017, 2022 & 2028)
3.5 United States Over The Counter (OTC) Drugs Market Size by Application (2017-2028)
4 Global Over The Counter (OTC) Drugs Competitor Landscape by Company
4.1 Global Over The Counter (OTC) Drugs Market Size by Company
4.1.1 Top Global Over The Counter (OTC) Drugs Companies Ranked by Revenue (2021)
4.1.2 Global Over The Counter (OTC) Drugs Revenue by Player (2017-2022)
4.2 Global Over The Counter (OTC) Drugs Concentration Ratio (CR)
4.2.1 Over The Counter (OTC) Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Over The Counter (OTC) Drugs in 2021
4.2.3 Global Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Over The Counter (OTC) Drugs Headquarters, Revenue in Over The Counter (OTC) Drugs Business (2017-2022) & (US$ Million) Type
4.3.1 Global Over The Counter (OTC) Drugs Headquarters and Area Served
4.3.2 Global Over The Counter (OTC) Drugs Companies Revenue in Over The Counter (OTC) Drugs Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Over The Counter (OTC) Drugs Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Over The Counter (OTC) Drugs Market Size by Company
4.5.1 Top Over The Counter (OTC) Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Over The Counter (OTC) Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Over The Counter (OTC) Drugs Market Size by Region
5.1 Global Over The Counter (OTC) Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Over The Counter (OTC) Drugs Market Size by Region (2017-2028)
5.2.1 Global Over The Counter (OTC) Drugs Market Size by Region: 2017-2022
5.2.2 Global Over The Counter (OTC) Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Over The Counter (OTC) Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Over The Counter (OTC) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Over The Counter (OTC) Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Over The Counter (OTC) Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Over The Counter (OTC) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Over The Counter (OTC) Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Over The Counter (OTC) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Over The Counter (OTC) Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Over The Counter (OTC) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Bayer AG
7.1.1 Bayer AG Company Details
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Over The Counter (OTC) Drugs Introduction
7.1.4 Bayer AG Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
7.1.5 Bayer AG Recent Development
7.2 Merck KGaA
7.2.1 Merck KGaA Company Details
7.2.2 Merck KGaA Business Overview
7.2.3 Merck KGaA Over The Counter (OTC) Drugs Introduction
7.2.4 Merck KGaA Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
7.2.5 Merck KGaA Recent Development
7.3 Novartis
7.3.1 Novartis Company Details
7.3.2 Novartis Business Overview
7.3.3 Novartis Over The Counter (OTC) Drugs Introduction
7.3.4 Novartis Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
7.3.5 Novartis Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Details
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Introduction
7.4.4 Johnson & Johnson Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
7.4.5 Johnson & Johnson Recent Development
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Details
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Over The Counter (OTC) Drugs Introduction
7.5.4 GlaxoSmithKline Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
7.5.5 GlaxoSmithKline Recent Development
7.6 Alkem Laboratories
7.6.1 Alkem Laboratories Company Details
7.6.2 Alkem Laboratories Business Overview
7.6.3 Alkem Laboratories Over The Counter (OTC) Drugs Introduction
7.6.4 Alkem Laboratories Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
7.6.5 Alkem Laboratories Recent Development
7.7 Teva Pharmaceutical Industries
7.7.1 Teva Pharmaceutical Industries Company Details
7.7.2 Teva Pharmaceutical Industries Business Overview
7.7.3 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Introduction
7.7.4 Teva Pharmaceutical Industries Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
7.7.5 Teva Pharmaceutical Industries Recent Development
7.8 Pfizer
7.8.1 Pfizer Company Details
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Over The Counter (OTC) Drugs Introduction
7.8.4 Pfizer Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
7.8.5 Pfizer Recent Development
7.9 Sun Pharma
7.9.1 Sun Pharma Company Details
7.9.2 Sun Pharma Business Overview
7.9.3 Sun Pharma Over The Counter (OTC) Drugs Introduction
7.9.4 Sun Pharma Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
7.9.5 Sun Pharma Recent Development
7.10 Allergan
7.10.1 Allergan Company Details
7.10.2 Allergan Business Overview
7.10.3 Allergan Over The Counter (OTC) Drugs Introduction
7.10.4 Allergan Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
7.10.5 Allergan Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
